NORML

FEBRUARY 1, 2019

Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017.

Patients 235

Patients Chronic Pain Therapy Data 235

The Cannigma

SEPTEMBER 28, 2023

1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant. hours to 6.79

Sleep 95

Sleep Data THC CBD 95

The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Here’s what they found.

Sleep 133

Sleep Data Tincture Research and Development 133

Cannabis Law Report

JANUARY 5, 2022

Starting this week, the Cannabis Control Commission (Commission)’s Open Data Platform composed of application and license, agent registration and ownership, and sales and product distribution information is now available on their main website at. MassCannabisControl.com/open- data. View the Open Data Platform.

Data 98

Data Treatment Programs Patients 98

NORML

OCTOBER 10, 2019

Some four in ten adults who reported using both marijuana and opioids within the past year acknowledge either decreasing or ceasing their consumption of opioids as a result of substituting cannabis, according to an analysis of survey data published in the journal PLOS One. ” authors concluded. ” authors concluded.

Patients 232

Patients Data Consumption Marijuana 232

Cannabis Law Report

APRIL 17, 2023

. — Oregon lawmakers are currently considering a bill that would require licensed psilocybin providers to submit data about their client’s demographics to state health officials.

Data 52

Data Collective Therapy Patients 52

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. The development has been welcomed and comes as the nation’s doctors are said to be shifting their cultural stance from viewing ‘cannabis as a dirty word’.

Data 52

Data Patients Clinical Trials Business 52

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 274

Chronic Pain Patients Therapy Data 274

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 243

Clinical Trials Chronic Pain Cannabinoids Patients 243

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. How Do MMJ Restrictions Affect Patients and Doctors? Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

JANUARY 16, 2024

As the natural remedy of cannabis gains more widespread acceptance and products become increasingly available, its healing properties are slowly gaining acceptance into mainstream culture. This paves the way for a more integrated approach to care where CBD can be used alongside traditional treatments to optimize patient outcomes.

Patients 113

Patients CBD Treatment Research and Development 113

Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Cannabis is an ideal substance to use during the various stages of cancer treatment but most especially after chemotherapy.

Patients 98

Patients Research and Development Treatment Consumption 98

Cannabis Life Network

JANUARY 16, 2022

People with AD are roughly around the age of 65 and according to recent data, increase every five to six years. The post Could CBD Help Patients With Alzheimer’s? appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

Patients 103

Patients CBD Data Treatment 103

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

NORML

APRIL 6, 2020

A team of researchers affiliated with the University of Miami School of Nursing are collecting epidemiological data to better evaluate how cannabis consumers, and patients in particular, are responding to the COVID-19 pandemic. So, we are combining our skills to do our part to provide that data.

Data 280

Data Access Patients Collective 280

The Cannigma

SEPTEMBER 18, 2023

The use of both cannabis and melatonin to fall asleep and stay asleep is hardly news. Cannabis has been used for relaxation for millennia , and the use of melatonin supplements increased by over 500% between 1999 and 2018. 7 fascinating ways cannabis can affect your body CBD, CBN, THC and melatonin for sleep So what’s working, exactly?

Sleep 83

Sleep Data THC CBD 83

SpeedWeed

JUNE 15, 2021

Ten Years Of Patient Data Supports Israeli Company’s Global Expansion – Cannabis Business Executive – Cannabis and Marijuana industry news. The post Ten Years Of Patient Data Supports Israeli Company’s Global Expansion – Cannabis Business Executive appeared first on SpeedWeed.

Data 40

Data Patients Business Cannabis 40

Healer

JANUARY 19, 2021

The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronic pain patients. Healer conducted an online convenience sample survey of patients from three medical cannabis practice sites who had reported using opioids. Peer Reviewed Medical Study .

Treatment 98

Treatment Data Chronic Pain Patients 98

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 172

Access Patients Chronic Pain Law 172

Veriheal

MAY 26, 2022

With new and improved products popping up left and right, legalization initiatives taking off all over the globe, and harmful “stoner” stigmas quickly dissipating, it’s clear that cannabis has entered a new era. The days of “reefer madness” are long over, replaced by a growing acknowledgment of the cannabis plant’s therapeutic abilities.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

The Fresh Toast

MAY 6, 2020

Medical Marijuana Leads To Less Hospitalizations For IBS Patients. New data shows IBS patients who used marijuana experienced less hospitalizations and shorter visits compared to non-users. The post Medical Marijuana Leads To Less Hospitalizations For IBS Patients appeared first on The Fresh Toast.

Patients 138

Patients Marijuana Data CBD 138

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

JULY 2, 2022

reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. What We Know About the Silverstreak Solutions Data Breach.

Data 52

Data Access Topical Cannabis 52

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

NOVEMBER 2, 2022

Cannabis Health Website reports New survey data reveals the myriad of issues facing UK patients, four years on from the legalisation of medical cannabis. Data collected from a recent survey paints a mixed picture of the experience of medical cannabis patients in the UK.

Patients 52

Patients Advocacy Data Collective 52

Veriheal

DECEMBER 14, 2021

In accordance with this, a new study found that states with legal cannabis markets have been less likely to experience incidences of EVALI, suggesting that properly regulated vape pens are not the problem. An Analysis of Nationwide EVALI Data. ” The study also discovered impacts from other variances in policies across states.

Data 98

Data Vaping Legalization Consumption 98

Cannabis Law Report

MARCH 31, 2022

South Dakota started approving medical cannabis patient and physician applications but at a rate that could make it difficult for patients to connect with doctors registered for the program. According to state rules, a physician is required to begin the process of applying for a medical cannabis card. Full report.

Patients 52

Patients Programs Data Cannabis 52

Cannabis Law Report

SEPTEMBER 6, 2022

WHILE Italy is both one of the earliest and largest medical cannabis markets in Europe, new data has revealed the ongoing inability of its system to ‘serve patients’ needs’. Despite the recovery from such a dramatic decline in 2020, this represented a fraction of the total medical cannabis sold in Italian pharmacies that year.

Data 52

Data Patients Cultivation Cannabis 52

Veriheal

DECEMBER 9, 2022

Medical cannabis put a huge dent in the opiate market, teens are ditching alcohol in favor of cannabis, and Colorado announced a new batch of labeling regulations. Cannabis Helps Cancer Patients Ditch Opiates, Study Finds. The patients came from 34 states that had not legalized medical cannabis by Jan.

Patients 97

Patients Cannabis Data Consumption 97

CannaMD

NOVEMBER 4, 2020

Cannabis has been used for centuries to manage chronic pain from all sources and, as a recent study highlights, its positive effects extend to migraines. and Canada to measure medical marijuana use among migraine patients and its effectiveness as a migraine treatment. 30 percent of migraine patients in the U.S. The results?

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Parkinson’s disease and cannabis. Interest among patients is high, but knowledge is limited.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Declining circulating tumor cell (CTC) count in treated patients.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

APRIL 28, 2021

If cannabis is to be accepted by the medical community (meaning patients, doctors, researchers, pharma companies, regulators…), there is much… Read More.

Data 98

Data Patients Cannabis 98

Cannabis Law Report

DECEMBER 13, 2022

The number of medical cannabis patients in Europe grew by almost 100,000 over the last year, according to new data, but access remains out of reach for many.

Patients 52

Patients Data Access Legalization 52

CannaMD

MARCH 4, 2020

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. Patients can learn more by visiting ReleafApp.com. Patients can learn more by visiting ReleafApp.com.

Patients 81

Patients Data Collective Treatment 81

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. There were three Cohorts, with 12 patients in each cohort. www.igcinc.us , www.igcpharma.com.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). The ORR is a web-based research platform open to adults and adult caregivers of dependents who are, or are considering, the use of cannabis or hemp products for therapeutic purposes.

Data 105

Data Epilepsy Research and Development Clinical Trials 105